Parallax Diagnostics Announces Intent to Develop a Rapid Screening Test for COVID-19 on its Patented FDA 510(K) Approved Diagnostic Platform
11 mars 2020 07h00 HE
|
Parallax Health Sciences, Inc.
Company will Partner to Accelerate The Deployment of Diagnostic Solutions Under Patent Protected Service Areas Including China, Hong Kong, India, and US NEW YORK, NY, March 11, 2020 (GLOBE...
Parallax Provides Mid-Quarter Update
24 févr. 2020 07h00 HE
|
Parallax Health Sciences, Inc.
Company Eliminates $25 Million Contingent Liability and Focuses Toward Operating Growth Parallax Licensing Program Moving Forward on All Fronts NEW YORK, NY, Feb. 24, 2020 (GLOBE NEWSWIRE) -- via...
Parallax Good Health Outcomes Mobile Application for Remote Patient Monitoring Now Available to Over 300,000 Patients in North America Through Existing Agreements
10 févr. 2020 07h00 HE
|
Parallax Health Sciences, Inc.
Critical Access Hospitals, Doctor Offices and Nursing Operations Contract with Parallax for Chronic Disease Management Capitalizing on New Reimbursement Landscape NEW YORK, NY, Feb. 10, 2020 (GLOBE...
Parallax Health Sciences Announces Patent Enforcement Initiative
06 janv. 2020 07h00 HE
|
Parallax Health Sciences, Inc.
Over $500 Million in Potential Infringement Damages Present in Diagnostic and Behavioral Markets NEW YORK, NY, Jan. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences,...
Parallax Health Sciences Engages Alston & Bird
02 janv. 2020 07h00 HE
|
Parallax Health Sciences, Inc.
New York, NY, Jan. 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax Health Sciences, Inc. (OTCQB: PRLX) (“Parallax”), an outcome-driven connected healthcare company, today announced that it...
Parallax Health Sciences Reports Third Quarter 2019 Financial Results
18 nov. 2019 06h00 HE
|
Parallax Health Sciences, Inc.
SANTA MONICA, Calif., Nov. 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax Health Sciences, Inc. (OTCQB: PRLX) (“Parallax”), an outcome-driven connected healthcare company, reports...
Parallax Behavioral Health Achieves Data Driven Outcomes Adoption and Vertical Market Integration
12 nov. 2019 08h00 HE
|
Parallax Health Sciences, Inc.
SANTA MONICA, Calif., Nov. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare...
Parallax Health Sciences Announces Acquisition of Minority Interest In Global Career Networks
19 sept. 2019 13h18 HE
|
Parallax Health Sciences, Inc.
SANTA MONICA, CA, Sept. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare...
Parallax Health Sciences Reports Second Quarter 2019 Financial Results
20 août 2019 06h00 HE
|
Parallax Health Sciences, Inc.
SANTA MONICA, Calif., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (“Parallax”), an outcome-driven connected healthcare company, reports financial results for June...
Parallax Health Sciences Announces Licensing Agreement With HealthPointe Solutions
18 juil. 2019 10h23 HE
|
Parallax Health Sciences, Inc.
Cognitive Artificial Intelligence and Data Analytics Combined with Outcomes Optimization for the Healthcare Market SANTA MONICA, CA, July 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax...